FDA Inspection 1297680 — Shandong Jincheng Kunlun Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Jincheng Kunlun Pharmaceutical Co., Ltd. on Dec 5, 2025 in Zibo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 5, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zibo (China)